Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2026 15:46 ET | Source: Pomerantz LLP

Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers – INO

NEW YORK, April 07, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Inovio Pharmaceuticals, Inc. (“Inovio” or the “Company”) (NASDAQ: INO) and...
April 07, 2026 13:44 ET | Source: BCC Research LLC

Global DNA Read, Write and Edit Market to Surge to $67.7 Billion by 2030, Driven by CRISPR Advances, Genomic Diagnostics and Expanding Clinical Applications

Rapid expansion in clinical applications, rising demand for genomic diagnostics, and increased investment in CRISPR-based therapeutics are fueling demand.
April 07, 2026 12:13 ET | Source: Research and Markets

Purvalanol A (CDK Inhibitor) Market Report 2026: Expanding Molecular Biology and Cancer Research Fuelling Market Growth

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Purvalanol A (CDK Inhibitor) Market Report 2026" has been added to ResearchAndMarkets.com's offering. The Purvalanol A (CDK Inhibitor) market has...
April 07, 2026 12:01 ET | Source: Research and Markets

Messenger RNA (mRNA) Market Projected to Reach $20.99 Billion by 2035 - Moderna, Pfizer, and Others Propel mRNA Expansion into New Therapeutic Areas

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Messenger RNA Market - A Global and Regional Analysis: Application and Regional Analysis - Analysis and Forecast, 2025-2035" has been added to ...
April 07, 2026 11:45 ET | Source: Transgene S.A.

Transgene to Participate in Upcoming Investor Meetings

Transgene to Participate in Upcoming Investor Meetings
April 07, 2026 10:30 ET | Source: Exousia Pro, Inc.

NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test

Exousia Pro, OTCPK: MAJI, announces the commencement of the first critical phase in bringing its revolutionary cancer screening test to the global market.
April 07, 2026 10:15 ET | Source: Octane Medical Group

BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform

WELLINGTON, New Zealand and KINGSTON, Ontario, April 07, 2026 (GLOBE NEWSWIRE) -- BioOra Limited ("BioOra"), a commercial-stage cell therapy company advancing CAR-T therapies for cancer patients,...
April 07, 2026 10:06 ET | Source: Research and Markets

Bio/Pharmaceutical Outsourcing Report, February 2026: Latest Business Conditions, New Outsourcing Contracts, Opportunity Assessment, Threats for Manufacturers, Mergers, Acquisitions, and Financing

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Bio/Pharmaceutical Outsourcing Report, February 2026" report has been added to ResearchAndMarkets.com's offering.The Bio/Pharmaceutical Outsourcing...
April 07, 2026 09:30 ET | Source: SNS Insider pvt ltd

Elemental Analysis Market to Surpass USD 5.18 Billion by 2035, Driven by Rising Demand for Precise Material Characterization | SNS Insider

Austin, April 07, 2026 (GLOBE NEWSWIRE) -- The Elemental Analysis Market size was valued at USD 2.86 billion in 2025 and is expected to reach USD 5.18 billion by 2035, growing at a CAGR of 6.17%...
April 07, 2026 09:28 ET | Source: Research and Markets

Dermatomyositis Global Clinical Trials Market Review Report 2026: Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End Point Status

Dublin, April 07, 2026 (GLOBE NEWSWIRE) -- The "Dermatomyositis - Global Clinical Trials Review, 2026" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides top...